ES2190160T3 - Combinacion medicamentosa para la terapia de la disfuncion erectil. - Google Patents

Combinacion medicamentosa para la terapia de la disfuncion erectil.

Info

Publication number
ES2190160T3
ES2190160T3 ES99118622T ES99118622T ES2190160T3 ES 2190160 T3 ES2190160 T3 ES 2190160T3 ES 99118622 T ES99118622 T ES 99118622T ES 99118622 T ES99118622 T ES 99118622T ES 2190160 T3 ES2190160 T3 ES 2190160T3
Authority
ES
Spain
Prior art keywords
drug combination
erectile dysfunction
cyclic
monophosphate
dysfunction therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99118622T
Other languages
English (en)
Inventor
Dr Dunzendorfer Pd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2190160T3 publication Critical patent/ES2190160T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Obtención de un medicamento en la forma de una combinación medicamentosa para el tratamiento de la disfunción eréctil compuesta de una sustancia que pueda inhibir:la fosfodiesterasa 5 y una segunda sustancia que pertenece a las Alpha simpaticomiméticas.
ES99118622T 1998-09-25 1999-09-21 Combinacion medicamentosa para la terapia de la disfuncion erectil. Expired - Lifetime ES2190160T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19844162A DE19844162A1 (de) 1998-09-25 1998-09-25 Medikamentenkombinationen zur Therapie der erektilen Dysfunktion

Publications (1)

Publication Number Publication Date
ES2190160T3 true ES2190160T3 (es) 2003-07-16

Family

ID=7882316

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99118622T Expired - Lifetime ES2190160T3 (es) 1998-09-25 1999-09-21 Combinacion medicamentosa para la terapia de la disfuncion erectil.

Country Status (5)

Country Link
EP (1) EP0995441B1 (es)
AT (1) ATE220909T1 (es)
DE (2) DE19844162A1 (es)
DK (1) DK0995441T3 (es)
ES (1) ES2190160T3 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114469A1 (en) * 2001-09-27 2003-06-19 Cohen David Saul Combinations
US6926741B2 (en) 2002-01-25 2005-08-09 Depuy Products, Inc. Centralizing cement plug with countersink
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
FR2649613B1 (fr) * 1989-07-11 1991-09-27 Virag Ronald Medicament vaso-actif
CA2314993A1 (en) * 1997-12-16 1999-06-24 Pfizer Products Inc. Combination effective for the treatment of impotence

Also Published As

Publication number Publication date
DE59902102D1 (de) 2002-08-29
DE19844162A1 (de) 2000-03-30
DK0995441T3 (da) 2002-10-28
EP0995441A3 (de) 2000-11-02
EP0995441A2 (de) 2000-04-26
EP0995441B1 (de) 2002-07-24
ATE220909T1 (de) 2002-08-15

Similar Documents

Publication Publication Date Title
BR9811927A (pt) Dispositivo de liberação de agente benéfico propelido por gás que pode ser implantado
ES2174274T3 (es) Dispositivo intramedular para la fijacion de huesos.
EA199901107A1 (ru) Системы и устройства для лечения переломов костей или больных костей с помощью расширяемых тел (варианты), стерильный набор инструментов для введения в кость (варианты)
PL1897518T3 (pl) Implant kręgowy oraz przyrząd do osadzania implantu
WO2005000161A3 (en) Methods and devices for occluding body lumens and/or for delivering therapeutic agents
DE50311038D1 (de) Endovaskuläres Implantat zur Injektion eines Wirkstoffs in die Media eines Blutgefässes
IL212777A0 (en) Baloon catheter
DE60131775D1 (de) Eine implantierbare oder einführbare vorrichtung zur abgabe therapeutischer mittel
DE602004029155D1 (de) Dilatations- und stentablagesystem
ATE552022T1 (de) Dentalspritze
SV2003001055A (es) Un agonista de a2a en combinacion con un agente anticolinergico para el tratamiento de enfermedades obstructivas de las vias areas
AR013479A1 (es) Metodo para aumentar el volumen oseo utilizando agonistas de prostanoide f selectivos no naturales.
BRPI0413974A (pt) combinação, método de tratamento de cáncer em um animal de sangue quente, composição farmacêutica, e, uso de uma combinação
ATE281171T1 (de) Pharmazeutische zusammensetzung zur immunstimulierenden therapie
ES2191298T3 (es) Cuerpo de implantes.
ES2190160T3 (es) Combinacion medicamentosa para la terapia de la disfuncion erectil.
ATE532469T1 (de) In eine menschliche oder tierische knochenstruktur einführbares konnektionsmittel und zugehöriges lokalisationssystem
MX9805939A (es) Formas solidas de administracion, de liberacion instantanea y procesos para su produccion.
ZA975028B (en) Finger-pressure functioning health-aid instrument for improving blood circulation in the human body.
ES2177097T3 (es) Utilizacion de extractos de ginkgo biloba para preparar un medicamento
CY1107227T1 (el) Θεραπεια αυτοανοσων νοσων με εκχυλισμα αμερικανικου γκινσενγκ
BR0115413A (pt) Tratamento de ejaculação precoce
SV2004001426A (es) Combinacion farmaceutica ref.pcs22049
WO2002030433A3 (de) Verwendung von stammzellen und cd6-depletierten stammzellen zur toleranzinduktion gegenüber allogenen transplantaten und/oder zur leukämiebehandlung
Sussman The role of antidepressants in sexual dysfunction.